Chinese Nationals Arrested in DOJ's Fentanyl Investigation

If you don't want to miss any of my intelligence, sign up for my regular newsletter at www.DrugIntelligenceBulletin.com. I post only occasionally to linkedin, but put out information weekly in the Drug Intel Bulletin.

The United States Department of Justice (DOJ) has unsealed three indictments against China-based chemical manufacturing companies and their employees. This marks the first prosecution of such companies and Chinese nationals for trafficking fentanyl precursor chemicals into the US. The charges stemmed from investigations that resulted in the seizure of over 200 kilograms of fentanyl-related precursor chemicals.

An Unprecedented Epidemic

Fentanyl, a synthetic opioid approximately 50 times more potent than heroin and 100 times more potent than morphine, has wreaked havoc in American communities. In 2022, the Centers for Disease Control and Prevention (CDC) reported an estimated 110,000 fentanyl-related deaths, making it the leading cause of death among Americans ages 18 to 49. The chemicals used to create this deadly drug are often sourced from foreign manufacturers.

Chinese Firms and Executives Indicted

The indicted Chinese companies include Hubei Amarvel Biotech Co. Ltd., aka AmarvelBio, and several associated executives and employees. Accusations against these firms and individuals include knowingly manufacturing, marketing, and supplying precursor chemicals for the production of fentanyl in the US.

Two individuals, Qingzhou Wang and Yiyi Chen, were arrested and will be appearing in the Manhattan federal court. Another individual, known as Er Yang, remains at large.

AmarvelBio's Role

The DOJ's indictment alleges that Amarvel Biotech has been involved in exporting substantial quantities of precursor chemicals for manufacturing fentanyl. They openly advertised the shipment of these chemicals to Mexico, where drug cartels operate. These cartels are known to produce finished fentanyl in clandestine labs before distributing it throughout the US.

Furthermore, Amarvel Biotech has also reportedly used deceptive packaging to disguise their shipments, such as labeling contents as dog food, nuts, or motor oil.

Challenging Times Ahead

The indictments unsealed in the Southern District of New York and Eastern District of New York represent a significant step in the fight against the opioid epidemic. These legal actions signal the intent to trace and challenge the supply chain for fentanyl production at its source.

Simultaneously, these actions underscore the necessity for continued collaboration and vigilance at a national and international level to thwart those who contribute to this ongoing crisis.

The case is being investigated by the DEA's Special Operations Division Bilateral Investigations Unit, with assistance from various other domestic and international agencies.